Skip to main content
. 2011 Mar 16;5(1):110–114. doi: 10.5009/gnl.2011.5.1.110

Fig. 1.

Fig. 1

Serum hepatitis C virus (HCV) RNA levels during therapy and follow-up of patients with posttreatment delayed viral clearance. (A) Patient 1. (B) Patient 2. (C) Patient 3. (D) Patient 4.

EOT, end of treatment.